A parasite invading human cells has a supply problem: it needs building material for new membranes, but it does not make every kind itself. This study finds it manufactures one form and steals another from its host.

Toxoplasma gondii can infect many types of cells in different vertebrates. Its fast-dividing form reproduces inside tissues and can eventually cause tissue destruction through repeated cycles of invasion and escape.

To reproduce inside a host cell, the parasite must produce enough membrane material through its own production and salvage pathways. Those pathways may offer targets for anti-parasitic treatment. The study examined two forms of a membrane fat during the parasite’s destructive growth cycle.

It focused on a protein that helps turn a small starting material into a building block for making that fat. The key question was whether the parasite makes these membrane fats itself, obtains them from the host, or uses both strategies. The parasite’s growth could be tested with a conditional switch that lowered the amount of this protein.

Without the switch, the altered parasite grew normally. With the switch lowering the protein, parasite growth stopped, leaving no visible plaques, meaning no zones of damage, in the host-cell layer. That result matched the observation that the protein’s gene could not simply be removed, showing that it has a critical role in the parasite’s life cycle.

When the protein was lowered, the parasite lost much of its total membrane-fat content, and all major classes of these fats decreased. The unchanged control cells did not show this effect. The two forms of the specific membrane fat behaved differently: the ester-linked form declined after ECT knockdown, while the ether-linked form did not.

So the balance between the two forms shifted strongly after the parasite’s own production route was disrupted. Removing this parasite protein disrupts nearly every step needed to spread: cell division, movement, entry into new host cells, and normal exit.

Triggering the exit signal can partly restore escape, but invasion falls to only a small fraction of normal, making movement the central link to the lethal outcome. A tracing experiment found the parasite adding the supplied starting material to several ester-linked membrane fats.

This confirmed that the parasite has an active internal route for making them. When the key protein was reduced, labeling fell in some of those fats, matching their decline. But labeling in two other ester-linked fats was unchanged, matching their stable or increased amounts.

The parasite uses distinct routes for the two forms of this membrane fat. The ester-linked form is produced through its own internal pathway, while the ether-linked form is salvaged from host cells. Because the key protein is essential for invasion and reproduction, and differs from related proteins in mammals, it could provide a route toward treatment for acute toxoplasmosis.

The study concludes that the key protein is vital for making the ester-linked membrane fat. Lowering it disrupts membrane production, reproduction, and invasion. The broader picture is a collaboration between internal production, chemical changes, and scavenging from the host.

In particular, the parasite can collect ether-linked membrane fats made by host cells, suggesting that its own production route could be targeted in treatment. The parasite depends on its own production line for one membrane fat, while importing another from the infected cell.

Blocking that production line stops invasion and reproduction, pointing toward a possible treatment target.